Results 71 to 80 of about 25,524 (191)

Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia.

open access: yesPLoS ONE, 2021
Early initiation of oseltamivir within 48 h to 5 days from illness onset has been associated with improved survival among patients with community-acquired influenza pneumonia.
Narongdet Kositpantawong   +7 more
doaj   +1 more source

Real‐World Claims Data on Prescribed Drugs and the Associated Drug–Drug Interaction Risk in Sickle Cell Disease in the United States

open access: yesClinical and Translational Science, Volume 19, Issue 10, October 2026.
Real‐world prescription data from 6230 adolescents and adults living with sickle cell disease (SCD) were combined with a drug–drug interaction (DDI) database to characterize the population‐level DDI risk. The findings support a DDI risk assessment for development of novel SCD therapies and during clinical management of SCD.ABSTRACTSickle cell disease ...
Rune Aabjerg Nørgaard   +4 more
wiley   +1 more source

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data

open access: yesHealth Technology Assessment, 2016
Background: Neuraminidase inhibitors (NIs) are stockpiled and recommended by public health agencies for treating and preventing seasonal and pandemic influenza. They are used clinically worldwide.
Carl J Heneghan   +11 more
doaj   +1 more source

From Real World Data to Real Impact: A Co‐Medication Framework for Lung Cancer to Advance DDI Assessment and Patient‐Centric Drug Development

open access: yesClinical and Translational Science, Volume 19, Issue 10, October 2026.
ABSTRACT Lung cancer predominantly affects older adults who already experience comorbidities and are at increased risk of drug–drug interactions (DDIs) due to polypharmacy. Traditional DDI assessments often do not fully capture complex co‐medication patterns observed in real‐world practice due to the risk of introducing confounding factors.
Mareena Biju   +6 more
wiley   +1 more source

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.

open access: yes, 2016
Oseltamivir and oseltamivir carboxylate concentrations were measured in venous plasma, venous blood, and capillary blood taken simultaneously from 24 healthy volunteers.

core   +1 more source

Volatile Relay Biosensing and Mobile Phone Imaging for Detection of Influenza Virus

open access: yesAdvanced Functional Materials, Volume 36, Issue 74, 14 September 2026.
Detection of volatile organic compounds is performed via a coupled enzymatic assay with mobile phone detection of the signal. Specific application demonstrated herein is the detection of influenza virus, across multiple levels of biological complexity, up to patient‐derived samples.
Dante G. Andersen   +7 more
wiley   +1 more source

Ultrathin Hydrogel Membranes Inspired by Soap Films Enable Physiologically Relevant Breathing Lung Models

open access: yesAdvanced Materials, Volume 38, Issue 53, 21 September 2026.
A soap‐film inspired strategy enables the fabrication of ultrathin yet robust GelMA‐PAAm membranes for breathing lung culture. The hydrogel membrane supports long‐term cyclic deformation under air‐liquid interface conditions, enabling physiologically relevant breathing motions of engineered lung tissue culture. ABSTRACT Breathing continuously stretches
Yunji Lee   +9 more
wiley   +1 more source

Synthesis and Biological activities of Oseltamivir phosphate (Tamiflu), Oseltamivir and Its Derivatives [PDF]

open access: yes, 2014
Oseltamivir  phosphate or TamifluTM 1, oseltamivir 2 and three new oseltamivir derivatives 11-13 were synthesized starting from (-)-shikimic acid 3.
Sritana-anant, Yongsak   +1 more
core  

Inhibition effect of oseltamivir for sialidase activities of oseltamivir-resistant and -sensitive viruses using 4MU-Neu5Ac or BTP3-Neu5Ac.

open access: yes, 2016
Sialidase activities of oseltamivir-resistant 738 (red circle) and -sensitive 838 (blue square) were measured in the presence of ten-fold serial dilutions of oseltamivir by using BTP3-Neu5Ac (A) or 4MU-Neu5Ac (B).
Yuuki Kurebayashi (235568)   +10 more
core   +1 more source

Pandemic (H1N1) 2009 and Seasonal Influenza A (H1N1) Co-infection, New Zealand, 2009

open access: yesEmerging Infectious Diseases, 2010
Co-infection with seasonal influenza A (H1N1) and pandemic (H1N1) 2009 could result in reassortant viruses that may acquire new characteristics of transmission, virulence, and oseltamivir susceptibility.
Matthew Peacey   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy